Fosmidomycin-Clindamycin for Plasmodium falciparum Infections in African Children
Fosmidomycin-Clindamycin for Plasmodium falciparum Infections in African Children
About this item
Full title
Author / Creator
Publisher
Chicago, IL: The University of Chicago Press
Journal title
Language
English
Formats
Publication information
Publisher
Chicago, IL: The University of Chicago Press
Subjects
More information
Scope and Contents
Contents
Background. Fosmidomycin is a new antimalarial drug with a novel mechanism of action. Studies in Africa that have evaluated fosmidomycin as monotherapeutic agent demonstrated its excellent tolerance, but 3-timesdaily treatment regimens of ⩾4 days were required to achieve radical cure, prompting further research to identify and validate a suitable c...
Alternative Titles
Full title
Fosmidomycin-Clindamycin for Plasmodium falciparum Infections in African Children
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_17969478
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17969478
Other Identifiers
ISSN
0022-1899
E-ISSN
1537-6613
DOI
10.1086/381785
